These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 31144198

  • 1. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F, Bahamondez-Canas TF, Smyth HDC.
    AAPS PharmSciTech; 2019 May 29; 20(5):205. PubMed ID: 31144198
    [Abstract] [Full Text] [Related]

  • 2. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F, Bahamondez-Canas TF, Moraga-Espinoza D, Smyth HDC, Watts AB.
    Eur J Pharm Biopharm; 2020 Jul 29; 152():210-217. PubMed ID: 32442738
    [Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
    Ahire JJ, Neveling DP, Hattingh M, Dicks LM.
    PLoS One; 2015 Jul 29; 10(4):e0123648. PubMed ID: 25853255
    [Abstract] [Full Text] [Related]

  • 4. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
    Ahmed MN, Porse A, Sommer MOA, Høiby N, Ciofu O.
    Antimicrob Agents Chemother; 2018 Aug 29; 62(8):. PubMed ID: 29760140
    [Abstract] [Full Text] [Related]

  • 5. In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.
    Brillault J, Tewes F, Couet W, Olivier JC.
    Eur J Pharm Sci; 2017 Jan 15; 97():92-98. PubMed ID: 27863308
    [Abstract] [Full Text] [Related]

  • 6. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
    Ahmed MN, Porse A, Abdelsamad A, Sommer M, Høiby N, Ciofu O.
    Antimicrob Agents Chemother; 2019 Oct 15; 63(10):. PubMed ID: 31307984
    [Abstract] [Full Text] [Related]

  • 7. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H, Chhibber S, Harjai K.
    Int J Antimicrob Agents; 2015 Apr 15; 45(4):359-67. PubMed ID: 25604277
    [Abstract] [Full Text] [Related]

  • 8. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
    Silva E, Monteiro R, Grainha T, Alves D, Pereira MO, Sousa AM.
    Front Cell Infect Microbiol; 2020 Apr 15; 10():441. PubMed ID: 32974221
    [Abstract] [Full Text] [Related]

  • 9. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J, Guo Y, Lu W, Liu X, Zhang J, Sun J, Chai G.
    Int J Pharm; 2024 Jun 10; 658():124208. PubMed ID: 38723731
    [Abstract] [Full Text] [Related]

  • 10. Mitigation of a nitrate reducing Pseudomonas aeruginosa biofilm and anaerobic biocorrosion using ciprofloxacin enhanced by D-tyrosine.
    Jia R, Yang D, Xu D, Gu T.
    Sci Rep; 2017 Jul 31; 7(1):6946. PubMed ID: 28761161
    [Abstract] [Full Text] [Related]

  • 11. Subinhibitory concentration of ciprofloxacin targets quorum sensing system of Pseudomonas aeruginosa causing inhibition of biofilm formation & reduction of virulence.
    Gupta P, Chhibber S, Harjai K.
    Indian J Med Res; 2016 May 31; 143(5):643-51. PubMed ID: 27488009
    [Abstract] [Full Text] [Related]

  • 12. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S, Zeighami H, Mirshahabi H, Bahari S, Soltani A, Haghi F.
    World J Microbiol Biotechnol; 2017 Mar 31; 33(3):50. PubMed ID: 28188589
    [Abstract] [Full Text] [Related]

  • 13. The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa.
    Shi N, Gao Y, Yin D, Song Y, Kang J, Li X, Zhang Z, Feng X, Duan J.
    Microb Pathog; 2019 Dec 31; 137():103765. PubMed ID: 31586475
    [Abstract] [Full Text] [Related]

  • 14. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A, Levato R, Julián E, Crespo A, Astola J, Gavaldà J, Engel E, Mateos-Timoneda MA, Torrents E.
    J Control Release; 2015 Jul 10; 209():150-8. PubMed ID: 25913364
    [Abstract] [Full Text] [Related]

  • 15. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS, Helfer VE, Bernardes PM, Macedo AJ, Nielsen EI, Friberg LE, Dalla Costa T.
    Antimicrob Agents Chemother; 2017 Jul 10; 61(7):. PubMed ID: 28461311
    [Abstract] [Full Text] [Related]

  • 16. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM, Herpin MJ, Kolacny D, Harb A, Romanovicz D, Smyth HD.
    Mol Pharm; 2016 Aug 01; 13(8):2760-70. PubMed ID: 27383205
    [Abstract] [Full Text] [Related]

  • 17. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
    Zhao T, Liu Y.
    BMC Microbiol; 2010 May 12; 10():140. PubMed ID: 20462423
    [Abstract] [Full Text] [Related]

  • 18. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
    Viganor L, Galdino AC, Nunes AP, Santos KR, Branquinha MH, Devereux M, Kellett A, McCann M, Santos AL.
    J Antimicrob Chemother; 2016 Jan 12; 71(1):128-34. PubMed ID: 26416778
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.
    Carneiro VA, de Oliveira ST, Silva RL, de Sousa Duarte H, Silva ML, Matos MNC, Cavalcante RMB, Figueira CS, Lorenzón EN, Cilli EM, da Cunha RMS.
    Protein Pept Lett; 2020 Jan 12; 27(11):1124-1131. PubMed ID: 32297570
    [Abstract] [Full Text] [Related]

  • 20. Real-Time Monitoring of nfxB Mutant Occurrence and Dynamics in Pseudomonas aeruginosa Biofilm Exposed to Subinhibitory Concentrations of Ciprofloxacin.
    Zaborskyte G, Andersen JB, Kragh KN, Ciofu O.
    Antimicrob Agents Chemother; 2017 Mar 12; 61(3):. PubMed ID: 27993856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.